AMENDMENT NO. 1 TO PRE-FUNDED WARRANTPre-Funded Warrant Amendment • May 15th, 2024 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMay 15th, 2024 Company Industry JurisdictionThis AMENDMENT NO. 1 TO PRE-FUNDED WARRANT (this “Amendment”) is effective as of April 26, 2023 by and between NLS PHARMACEUTICS LTD., a corporation incorporated under the laws of Switzerland (the “Company”) and the holders of certain Pre-Funded Warrants (as herein defined) as set forth on Appendix A annexed hereto (the “Holder”). Each of the Company and the Holder shall be referred to collectively as the “Parties” and individually as a “Party.”
AMENDMENT NO. 1 TO PRE-FUNDED WARRANTPre-Funded Warrant Amendment • July 9th, 2019 • DarioHealth Corp. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJuly 9th, 2019 Company Industry JurisdictionThis AMENDMENT NO. 1 TO PRE-FUNDED WARRANT (this “Amendment”) is effective as of July __, 2019 by and between DarioHealth Corp., a Delaware corporation (the “Company”) and the holders of certain Pre-Funded Warrants (as herein defined) as set forth on Appendix A annexed hereto (the “Holder”). Each of the Company and the Holder shall be referred to collectively as the “Parties” and individually as a “Party.”
AMENDMENT NO. 1 TO PRE-FUNDED WARRANTPre-Funded Warrant Amendment • May 5th, 2023 • NLS Pharmaceutics Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMay 5th, 2023 Company Industry JurisdictionThis AMENDMENT NO. 1 TO PRE-FUNDED WARRANT (this “Amendment”) is effective as of April 26, 2023 by and between NLS PHARMACEUTICS LTD., a corporation incorporated under the laws of Switzerland (the “Company”) and the holders of certain Pre-Funded Warrants (as herein defined) as set forth on Appendix A annexed hereto (the “Holder”). Each of the Company and the Holder shall be referred to collectively as the “Parties” and individually as a “Party.”